Bacteriophage for the treatment of bacterial biofilms
4 Assignments
0 Petitions
Accused Products
Abstract
The present invention provides a composition for treating a bacterial biofilm, comprising a first bacteriophage that is capable of infecting a bacterium within said biofilm, and a first polysaccharide lyase enzyme that is capable of degrading a polysaccharide within said biofilm. The composition preferably further comprises a pharmaceutically-acceptable antimicrobial agent, and may also include a DNase. Also provided are modified bacteriophages, methods of creating modified bacteriophages, use of said compositions and bacteriophage for treating biofilms, and methods for treating biofilms using the bacteriophages and compositions of the invention.
39 Citations
87 Claims
-
1-40. -40. (canceled)
- 41. A composition for treating a bacterial biofilm, wherein the biofilm is a lung biofilm of a cystic fibrosis patient, comprising a first bacteriophage that is capable of infecting a bacterium within said biofilm, a first polysaccharide lyase enzyme that is capable of degrading a polysaccharide within said biofilm, and a pharmaceutically-acceptable antimicrobial agent.
-
57. A GH bacteriophage selected from the group consisting of GH4 (ECACC Accession No. 02121203), GH6 (ECACC Accession No. 02121202), GH13 (ECACC Accession No. 02121201), and GH14 (ECACC Accession No. 02121204).
-
58. A method of treating a biofilm infection, wherein the biofilm is a lung biofilm in a cystic fibrosis patient, comprising administering to the patient:
-
a first bacteriophage capable of infecting a bacterium within said biofilm;
a first polysaccharide lyase enzyme capable of degrading a polysaccharide within said biofilm; and
a pharmaceutically-acceptable antimicrobial agent. - View Dependent Claims (59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76, 77, 78, 79, 80, 81)
-
-
82. A method of making a modified bacteriophage capable of degrading a biofilm, wherein the biofilm is a lung biofilm of a cystic fibrosis patient, comprising:
-
a) selecting at least one gene encoding a polysaccharide lyase enzyme that degrades a polysaccharide within said biofilm;
b) selecting a bacteriophage that is capable of infecting a bacterial species or strain residing within the biofilm; and
c) introducing at least one of the genes selected in step a) into the bacteriophage nucleic acid. - View Dependent Claims (83, 84, 85, 86)
-
-
87. A method of identifying a bacteriophage for use in treatment of a biofilm, wherein the biofilm is a lung biofilm of a cystic fibrosis patient, comprising:
-
a) identifying a bacteriophage that is capable of infecting a bacterial species or strain within said biofilm; and
b) confirming that said bacteriophage encodes a polysaccharide lyase that degrades a polysaccharide within the biofilm.
-
Specification